MARSHALL WACE, LLP - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 83 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2019. The put-call ratio across all filers is 1.57 and the average weighting 0.9%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2021$67,000
-96.4%
15,572
-94.6%
0.00%
-100.0%
Q1 2019$1,866,000
+172.4%
289,954
+299.2%
0.01%
+28.6%
Q4 2018$685,00072,6380.01%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q1 2019
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,018,00094.79%
TANG CAPITAL MANAGEMENT LLC 9,405,490$39,879,00011.22%
RTW INVESTMENTS, LP 2,327,903$9,870,0000.15%
Boxer Capital, LLC 890,700$3,777,0000.13%
FIRST MIDWEST BANK TRUST DIVISION 89,341$379,0000.05%
WealthTrust Axiom LLC 30,400$128,0000.04%
PREMIER ASSET MANAGEMENT LLC 51,305$217,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 18,113$77,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 39,000$165,0000.02%
Inscription Capital, LLC 10,000$42,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders